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An International Comparison of Cancer
Survival: Metropolitan Toronto, Ontario,
and Honolulu, Hawaii

A B S T R A C T
Objectives. Comparisons of cancer
survival in Canadian and US metropolitan areas have shown consistent Canadian advantages. This study tests a health
insurance hypothesis by comparing cancer survival in Toronto, Ontario, and
Honolulu, Hawaii.
Methods. Ontario and Hawaii registries provided a total of 9190 and 2895
cancer cases (breast and prostate, 1986–
1990, followed until 1996). Socioeconomic data for each person’s residence at
the time of diagnosis were taken from
population censuses.
Results. Socioeconomic status and
cancer survival were directly associated
in the US cohort, but not in the Canadian cohort. Compared with similar patients in Honolulu, residents of lowincome areas in Toronto experienced
5-year survival advantages for breast and
prostate cancer. In support of the health
insurance hypothesis, between-country
differences were smaller than those observed with other state samples and the
Canadian advantage was larger among
younger women.
Conclusions. Hawaii seems to provide better cancer care than many other
states, but patients in Toronto still enjoy
a significant survival advantage. Although Hawaii’s employer-mandated
health insurance coverage seems an effective step toward providing equitable
health care, even better care could be expected with a universally accessible,
single-payer system. (Am J Public
Health. 2000;90:1866–1872)
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Kevin M. Gorey, PhD, MSW, Eric J. Holowaty, MD, FRCPC, MSc, Gordon Fehringer,
MSc, Ethan Laukkanen, MD, FRCPC, Nancy L. Richter, MSW, and
Cynthia M. Meyer, BSW
A recent study of cancer survival in
Toronto, Ontario, and in Detroit, Michigan,
compared their ecologically defined poor and
found advantaged survival among Canadians
for 13 of 15 cancer sites (weighted mean 5year survival rate ratio [SRR]=1.55).1,2 This
consistent pattern of Canadian cancer survival
advantage was then systematically replicated
with 3 more economically resourceful US metropolitan areas (Seattle, Wash; San Francisco,
Calif; and Hartford, Conn).3 Again, significantly better 5-year survival rates were observed for 13 of 15 common types of cancer
among the relatively poor of Toronto compared
with similarly poor US subjects (SRR=1.35).
Moreover, no such between-country differentials were observed in the middle- or highincome groups. Cancer survival reported in the
first Canada–US comparative study in this research field was substantively similar.4 However, that study’s essentially nonsignificant
findings are not surprising, as it did not include
any measure of socioeconomic status (SES).
It merely compared cohorts across all aggregated SES levels and so could not observe any
modification of between-country survival differences by SES.
Another recent study, which systematically replicated Canadian cancer survival advantages among those who live in relatively
poor communities, probably compromised internal validity in its attempt to extend external
validity.5 Its aggregate comparison of the
province of Ontario with a sample of the entire
United States may have been confounded by
other than socioeconomic variability related to
the diverse metropolitan, exurban, and rural
residences represented among its samples or,
relatedly, by the size of its ecologic units of
analysis, which ranged by a factor of more than
1000, from smaller areal units (e.g., census
tract, 0.5 km2) typical of metropolitan areas to
much larger census subdivision or county units
(e.g., 500 km2) more typically used in other
areas. The present study attempts to extend this
research field’s external validity without making such compromises.

The central inference has been that a key
structural difference between Canada and the
United States—single-payer vs multipayer
health care systems—is the most cogent explanation for the observed consistent pattern
of Canadian survival advantage across various
cancer sites; that is, the more equitable access
they offer to preventive and therapeutic health
care services is responsible for the differences.
In the United States, insurance status—noninsured or underinsured vs some insurance or
better insured—has been found to be strongly
associated with the receipt of primary care, the
receipt of cancer screening services, stage of
cancer at the time of diagnosis,6–15 receipt of
various cancer treatments,16–20 and survival of
cancer (weighted risk ratios consistent with
disadvantage among the uninsured ranged from
1.50 to 10.00).21–26 Cancer care in Canada has
not been without its apparent inequities. For
example, a socioeconomic mammography gradient, albeit much smaller than the US one,
was observed in Canada in the mid-1980s
along with evidence of higher screening rates
among American women.27,28 More recent samples, however, have demonstrated that federal
and provincial initiatives have substantially reduced or eliminated these inequities.29
The fact that the more prevalent screening
participation among American women was not
attendant with earlier stage at diagnosis or survival advantages underscores the probable
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importance of other prevention strategies such
as the opportunity to develop an ongoing, continuous relationship with a primary care physician. Such more generalist life-course preventive interventions probably are more readily
available in Canada, particularly among the
relatively poor. Given that previous studies have
provided substantial adjustments for absolute
income status, race/ethnicity and culture, differential longevity, and competing causes of
death and that the consistent pattern of the
Canadian advantage has been observed across
divergent types of cancer (e.g., some associated with lifestyle, others not), the developing
health insurance theory certainly seems to hold
prima facie validity.
The present analysis tests the health insurance hypothesis by means of a systematic
replication of previous Canada (Toronto)–US
cancer survival comparisons with a US metropolitan sample from Hawaii, a state that is
atypical in its history of offering health insurance coverage to its residents. Hawaii has mandated employer-based health insurance coverage since 1974, and through related legislation
it has also endeavored to insure people employed part-time as well as those unemployed.
Estimates of Hawaii’s prevalent health insurance coverage have ranged from 89% to 98%
(median estimate=96%).30–34 Such a legislative mandate has not guaranteed everyone
health insurance, and Hawaii has not been able
to completely eliminate all health status inequities (traditional “at-risk” groups [e.g., Native Hawaiians] and geographic service variabilities still exist). Nevertheless, Hawaii seems
to stand alone among US states in minimizing
the risk of being uninsured. During the mid1980s to the mid-1990s, the period during
which the international research on cancer survival was performed, the prevalence of Hawaii’s
uninsured typically has been half to one quarter that of most other states. We therefore hypothesized that relatively poor Hawaiians would
enjoy a cancer survival experience more similar to that of their relatively poor Canadian
counterparts, although we still hypothesized
advantaged survival among Canadians.

Methods
Cancer cases arose from the populations
of greater metropolitan Toronto, Ontario
(Toronto, York, and Peel regions; population
3.5 million in 1991), and Honolulu, Hawaii
(Honolulu County; population 825 000 in
1991).35,36 Metropolitan samples were selected
to provide some control for natural health care
service endowment. Physician and hospitalbased preventive, investigative, and therapeutic oncology services, although they may not be
equitably accessible, are well known as the
December 2000, Vol. 90, No. 12

most available in such areas of Canada and the
United States. The data sources were the Ontario Cancer Registry (Toronto data) and the
National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program
(Honolulu data). Definitions of the study cohorts were constrained by the following: 1986
was the first year in which the Ontario Cancer
Registry coded the postal code of residence for
most cases, and cohort termination or the date
of last follow-up for both cohorts was December 31, 1995.37,38 A 5-year survival analysis was based on cumulative incident cases diagnosed from 1986 to 1990. Power calculations
based on the between-country comparisons reported in the original Toronto–Detroit study as
well as 3 statistical criteria (2-tailed test; power,
defined as [1– β]=.80; and α=.05 [95% confidence intervals])1,39 determined that there
would be sufficient power to detect meaningful between-country differences for breast and
prostate cancer, the 2 most common types of
cancer for which preventive and therapeutic
interventions are expected to make a difference. All primary malignant cancers of the
breast among women and of the prostate
among men that occurred in adults (25 years or
older) were included in the analysis (5807
breast and 3383 prostate cancer cases in
Toronto and 1783 breast and 1112 prostate cancer cases in Honolulu).
The present analysis, like the original, used
a census-based SES measure (census tract proportion meeting a “low-income” criterion in
Canada and “poverty” threshold in the United
States) to define relative income quantiles.35,36
Its critical comparisons were therefore between
corresponding income tertiles and deciles in
Toronto and Honolulu. Descriptive profiles of
the resultant income areas that are displayed in
Table 1 demonstrate 2 methodologically important principles: (1) the construct validity of
this study’s ecologic measures of relative SES
is supported by the clear median income hierarchies—relatively low to high income areas—
observed in bothToronto and Honolulu, and (2)
even though Statistics Canada’s low-income criterion is much more liberal than the US Census
Bureau’s poverty threshold, the corresponding
Toronto–Honolulu relative income areas are
strikingly similar in terms of their typical incomes (and population sizes and areas; see
Table 1 footnotes a and b), providing substantial
ecologic control for absolute economic status.
This study’s Honolulu cohort was nearly identical to the original Toronto and other US cohorts on data quality indicators: 97.5% of their
residences (census tracts) at the time of diagnosis were coded, 95.9% of the cancers were microscopically confirmed, and 0.8% were enumerated on the basis of death certificates only.37,38
Analytically, the present study’s 5-year
survival analysis was a near-exact replicate of

the original. Survival rates were directly age
adjusted on the basis of this study’s combined
Toronto–Honolulu population of cases by each
specific cancer site across the following age
strata: 25–44, 45–54, 55–64, 65–74, and 75
years or older. Among all the breast and
prostate cancer cases in which the patient was
dead at follow-up, 79% and 63%, respectively,
of the patients died as a direct result of cancer.
Among the sample of cases diagnosed before
65 years of age, however, nearly all subsequent
deaths were attributable to cancer (90% and
81%, respectively). Cancer survival comparisons across specific income area strata were
then performed, so that SRRs were greater than
1.00 if Toronto residents were advantaged and
less than 1.00 if Honolulu residents were advantaged. Ninety-five-percent confidence intervals around survival rate ratios were based
on the Mantel-Haenszel χ2 test.40,41 Throughout the text, when referring to SRR point estimates that “approached statistical significance,”
we specifically mean that although their associated 95% confidence intervals intersected
the null (not significant at α=.05), their corresponding 90% confidence intervals did not
(significant at α=.10).

Results
This study systematically replicated the
findings of previous Canadian–US cancer survival analyses across socioeconomic tertiles—
low-, middle-, and high-income areas—in the
following 3 ways (top of Table 2).
1. The Toronto samples of breast and
prostate cancer cases that extended previous
analyses by 2 years continued to demonstrate
no association between SES and cancer survival, whereas the Honolulu samples did; 5year survival rates were significantly lower in
Honolulu’s relatively low-income areas (breast
and prostate cancer low-income vs high-income
SRRs were 0.94 and 0.85, respectively).
2. The 2 countries’ samples did not differ
significantly on cancer survival in the middleor high-income groups.
3. As hypothesized for low-income
groups, significantly advantageous survival in
Toronto was observed for both breast cancer
(SRR=1.06) and prostate cancer (SRR=1.10).
Also as hypothesized, the Toronto advantage
was much smaller than had been observed with
its previous comparison with Detroit; the corresponding Toronto–Detroit breast and prostate
SRRs were 1.30 and 1.21.1
Consistent with a health insurance explanation for the observed SES–cancer survival
associations in the United States, along with
the observed survival advantages among Canadians who live in relatively low-income areas
American Journal of Public Health
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TABLE 1—Descriptive Profiles of Census Tract–Based Income Areas in Toronto, Ontario (1991), and Honolulu, Hawaii (1990)

Income Group

Toronto, Ontarioa
Low-Income Prevalence
Range
Median

Income ($)c

Honolulu, Hawaiib
Poverty Prevalence
Range
Median

Income ($)c

Income tertiles
Highest
1
2
3
Lowest

1.30–9.40
9.41–17.14
17.15–66.75

5.63
11.69
22.65

56 639
43 315
30 377

0.00–3.29
3.30–7.89
7.90–68.65

1.97
5.38
16.70

57 965
42 780
30 012

0.00–1.59
1.60–2.29
2.30–2.99
3.00–3.89
3.90–5.29
5.30–6.79
6.80–8.59
8.60–10.79
10.80–17.49
17.50–68.65

0.81
1.90
2.69
3.28
4.80
6.02
7.44
9.53
13.90
24.42

61 384
59 130
54 798
52 380
43 502
39 280
38 144
32 690
30 979
21 420

Income deciles
Highest
1
2
3
4
5
6
7
8
9
10
Lowest

1.30–5.09
5.10–6.99
7.00–8.99
9.00–10.89
10.90–12.49
12.50–15.09
15.10–18.39
18.40–22.69
22.70–27.69
27.70–66.75

3.75
5.95
7.60
9.55
11.50
13.51
16.32
20.19
25.00
32.10

58 741
57 161
54 389
49 886
47 117
42 276
39 628
34 337
32 010
25 090

a

Population of 3 498 768 in 1991: 728 census tracts with a mean population of 4806 (SD = 1825) and a median population of 4742. Excluding
the small number of outlying tracts (2.6% of 50 km2 or larger), census tracts typically had areas of 1 km2 or less (40%) and a median area of
1.15 km2 (mean = 2.53, SD = 4.84).
b
Population of 824 600 in 1990: 190 census tracts with a mean population of 4340 (SD = 2074) and a median population of 4200. Excluding the
small number of outlying tracts (5.3% of 50 km2 or larger), census tracts typically had areas of 1 km2 or less (45%) and a median area of
1.25 km2 (mean = 3.61, SD = 5.70).
c
Census tract median annual household income in US dollars.

compared with their US counterparts, most
such associations were larger when the analysis was restricted to patients diagnosed before
the age of 65 years who were not yet eligible
for Medicare coverage in the United States
(bottom of Table 2). Among these younger
breast cancer cohorts, which made up 61% of
this study’s sample of women with breast cancer, the low-income vs high-income SRR in
Honolulu was 0.88 (the middle-income vs
high-income SRR approached statistical significance [0.93]). Among low-income groups,
even better survival was observed in Toronto vs
Honolulu (SRR=1.12) than had been observed
among the breast cancer cases involving patients of all ages. None of the within-country
or between-country breast cancer survival comparisons were significant among the sample
of women 65 years or older (not shown in
Table 2). As for the younger prostate cancer
cohorts, which made up only 18% of the sample of men with prostate cancer, a remarkably
similar pattern of within- and between-country
disadvantage among Honolulu’s relatively poor
was observed, although it was generally characterized by point estimates that approached
statistical significance and nonsignificant
trends. Unlike older women with breast cancer,
older prostate cancer patients in relatively lowincome areas remained disadvantaged regarding 5-year cancer survival compared with their
1868
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counterparts in relatively high-income areas
(SRR=0.87; 95% confidence interval [95%
CI]=0.77, 0.99).
We then expanded these analyses across
income decile groups to characterize cancer
survival differences across more diverse socioeconomic areas, from the categorically most
affluent to the most impoverished underclass
neighborhoods (Table 3). The following 3 patterns, of interest with regard to health care policy, emerged from this systematic replication.
1. Even with greatly expanded socioeconomic variability across 10 income areas, no association was observed between SES and cancer
survival in the Canadian sample; the stark similarity of breast and prostate cancer survival in
Toronto was maintained, even when the lowestincome decile was compared with the highest.
2. The poorest US income areas were extremely disadvantaged compared with the most
affluent ones; 5-year survival rates were significantly lower in Honolulu’s lowest-income
areas (breast and prostate cancer lowest-income
vs highest-income decile SRRs were 0.78 and
0.69, respectively). Among the Honolulu sample of women younger than 65 years with breast
cancer, the socioeconomic survival gradient
was even larger (lowest-income vs highestincome decile SRR=0.69; 95% CI=0.52, 0.91;
not shown in Table 3).

3. Consistent with previous tertile-based
analyses, significantly advantageous survival
among the lowest-income groups in Toronto
was observed for both breast cancer (SRR =
1.20) and prostate cancer (SRR=1.24).Among
women younger than 65 years with breast cancer, the estimate of advantaged Canadian survival was even greater (SRR=1.28; 95% CI=
1.07, 1.53; not shown in Table 3).
It is also important to note that a pattern
of diminished survival typically approaching
statistical significance was observed among
Honolulu’s breast and prostate cancer patients
who lived in Honolulu’s fifth through eighth
income deciles, which may be categorically
defined as representing middle-class to lowermiddle- or working-class neighborhoods
(SRRs ranged from 0.80 to 0.90). Relatedly,
in the sixth decile, fewer such middle-income
women with breast cancer survived for 5 years
than did their Canadian counterparts (SRR=
1.10). Finally, the Toronto–Honolulu breast
cancer (SRR=0.91) and prostate cancer (SRR=
0.89) SRR estimates that approached statistical significance and were nonsignificant, respectively, suggested that among the most economically resourceful cancer patients who live
in the wealthiest 10% of North American
neighborhoods, Americans may enjoy a survival advantage.
December 2000, Vol. 90, No. 12

Discussion
We studied the effect of SES on survival
from breast and prostate cancer among the adult
populations ofToronto, Ontario, and Honolulu,
Hawaii. In within-country comparisons, breast
and prostate cancer survival in Honolulu was
significantly poorer (on the basis of 95% confidence interval) among people from lower socioeconomic areas. These SES–survival associations were larger for steeper socioeconomic
gradients (income deciles vs tertiles) and among
younger breast cancer patients (younger than
65 years) not yet eligible for Medicare participation. No such associations were found among
Toronto’s population. In the between-country
analysis that compared cases arising from
Toronto and Honolulu’s low-income areas (lowest third and lowest tenth), we found a consistently significant survival advantage inToronto
that was, again, even larger among younger
breast cancer patients. Furthermore, we found
more tentative evidence of a smaller survival
advantage in Toronto among some categorical
middle-class patients and a concomitant advantage in the United States among some upperclass patients.
This pattern of findings points toward the
different health care systems in Canada and
the United States (single-payer vs multipayer)
as its most cogent explanation. Because of

Hawaii’s more prevalent health insurance coverage, we predicted (correctly) that it would
have a cancer survival experience more similar to a that of a Canadian sample than US samples in previous Canadian–US comparative
studies had. This study’s general pattern of results, along with its somewhat attenuated observed associations, substantiates the health insurance hypothesis as an explanation for
Canadian–US differences on cancer survival,
particularly among the relatively poor but also
among middle-class and more affluent cancer
patients.
Among the poor, this study’s findings are
consistent with the well-known strong associations of health insurance status—no insurance or underinsured vs some or adequate coverage—with SES in the United States.42
Notwithstanding questions about the relative
effectiveness of Medicaid, America’s health
care program for the poor, this study’s relatively poor areas contained almost 2 “nearpoor” people (up to 200% of the federally established poverty criterion) for each of their
poor residents. Many such marginally impoverished people, while generally not meeting
Medicaid’s means test, probably have difficulty
purchasing private health insurance. As for this
study’s middle-class or working-class neighborhoods, these also include significant enclaves of the near poor (2-fold to 3-fold more

prevalent than the poor in this study’s US sample), including the working poor as well as
better-off working people who, for a number of
social structural and economic reasons, remain
uninsured or underinsured.42 The tentative evidence that American cancer survival advantage is enjoyed by only a very select few—that
is, the most affluent 10% of the population—
only serves to further indict the American
health care system. It seems to suggest that
only the most fortunate, generally well-insured
people with ample disposable incomes can expect the best that the US health care system
has to offer.
Hawaii’s pattern of cancer survival, which
is more similar to that of Canada, and its
smaller SES–cancer survival gradients are different from what has been observed in other
states (California, Connecticut, Michigan, and
Washington).1–3 These findings are certainly
consistent with Hawaii’s much greater prevalence of health insurance coverage; they are
also consistent with secular trends within
Hawaii. Whereas others have recently found
no association between SES and breast cancer
survival in Hawaii, the gradient most typical
of other states (lower survival rates among the
poor) was observed there in earlier cohorts
from the 1960s through 1970s.43,44 The previously observed pattern of advantaged Hawaiian cancer survival within the United States is

TABLE 2—Association of Income Tertiles With Breast and Prostate Cancer 5-Year Survival: Toronto, Ontario, and Honolulu,
Hawaii
Cancer Site (ICD-9 Code)
and Income Group

n

Toronto, Ontario
SR
SRRa

(95% CI)b

n

Honolulu, Hawaii
SR
SRRa
(95% CI)b

Toronto/Honolulu Cases
SRRa
(95% CI)b

All adult cancer cases
Breast (174)
High
Middle
Low
Prostate (185)
High
Middle
Low
Breast (174)
High
Middle
Low
Prostate (185)
High
Middle
Low

2350
1582
1875

.710
.716
.724

1.00
1.01
1.02

...
(0.97, 1.06)
(0.98, 1.06)

595
613
575

1413
927
1043

.579
.555
.569

1432
940
1110

.760
.749
.771

1.00
0.99
1.01

...
(0.96, 1.02)
(0.98, 1.04)

418
378
360

263
173
207

.736
.730
.698

1.00
0.99
0.95

...
(0.91, 1.08)
(0.86, 1.05)

60
63
43

.728
.699
.684

1.00
0.96
0.94

...
(0.89, 1.03)
(0.88, 1.00)

0.98
1.02
1.06

(0.94, 1.03)
(0.97, 1.07)
(1.00, 1.12)

1.00
0.92
0.85
y

...
(0.81, 1.05)
(0.74, 0.97)

0.96
1.00
1.10

(0.88, 1.05)
(0.93, 1.07)
(1.00, 1.22)

.785
.731
.689

1.00
0.93
0.88

...
(0.86, 1.01)c
(0.81, 0.96)

0.97
1.02
1.12

(0.92, 1.03)
(0.96, 1.08)
(1.04, 1.20)

.749
.684
.614

1.00
0.91
0.82

...
(0.73, 1.13)
(0.64, 1.05)c

0.98
1.07
1.14

(0.80, 1.20)
(0.88, 1.30)
(0.92, 1.41)

1.00
...
327
.605
0.95
(0.87, 1.03)
373
.557
0.98
(0.91, 1.06)
412
.517
Adult cancer case patients younger than 65

Note. ICD-9 = International Classification of Diseases, Ninth Revision; n = number of cumulative incident cancer cases; SR = cumulative survival
rate; SRR = survival rate ratio; CI = confidence interval. Within- and between-country comparisons among adult cancer case patients 65 years
or older are excluded from the table because all except 1 of them (reported in the text) were not minimally statistically significant. Because
statistical power is clearly insufficient to detect meaningful between-country differences among relatively young men with prostate cancer,
this exploratory subanalysis ought to be interpreted with extreme caution until it is either confirmed or refuted with larger samples.
a
A survival rate ratio of 1.00 is the baseline.
b
Confidence intervals are based on the Mantel-Haenszel χ2 test.
c
Approached statistical significance: 90% confidence interval does not intersect the null value of 1.00.
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TABLE 3—Association of Income Deciles With Breast and Prostate Cancer 5-Year Survival: Toronto, Ontario, and
Honolulu, Hawaii

Income Group

n

Toronto, Ontario
SR
SRRa

(95% CI)b

n

Honolulu, Hawaii
SR
SRRa

(95% CI)b

.774
.730
.717
.751
.723
.620
.697
.750
.704
.600

1.00
0.94
0.93
0.97
0.93
0.80
0.90
0.97
0.91
0.78

...
(0.82, 1.07)
(0.81, 1.06)
(0.86, 1.09)
(0.81, 1.07)
(0.69, 0.93)
(0.79, 1.02)c
(0.87, 1.09)
(0.80, 1.04)
(0.67, 0.91)

.638
.644
.569
.579
.508
.585
.527
.523
.580
.440

1.00
1.01
0.89
0.91
0.80
0.92
0.83
0.82
0.91
0.69

Toronto/Honolulu Cases
SRRa
(95% CI)b

Breast cancer
Highest
1
2
3
4
5
6
7
8
9
10
Lowest

685
777
737
472
488
453
422
597
457
719

.705
.711
.713
.726
.734
.682
.708
.724
.743
.718

1.00
1.01
1.01
1.03
1.04
0.97
1.00
1.03
1.05
1.02

...
(0.93, 1.10)
(0.95, 1.08)
(0.96, 1.11)
(0.97, 1.12)
(0.90, 1.04)
(0.81, 1.24)
(0.95, 1.11)
(0.98, 1.13)
(0.95, 1.10)

120
272
157
147
192
186
177
223
157
152

0.91
0.97
0.99
0.97
1.02
1.10
1.02
0.97
1.06
1.20

(0.81, 1.02)c
(0.89, 1.06)
(0.89, 1.10)
(0.87, 1.08)
(0.87, 1.19)
(0.98, 1.23)c
(0.91, 1.15)
(0.89, 1.05)
(0.95, 1.18)
(1.06, 1.36)

0.89
0.92
1.02
0.99
1.03
0.95
1.08
1.09
0.97
1.24

(0.73, 1.08)
(0.79, 1.07)
(0.76, 1.36)
(0.75, 1.31)
(0.86, 1.23)
(0.77, 1.17)
(0.90, 1.29)
(0.93, 1.28)
(0.83. 1.13)
(1.01, 1.53)

Prostate cancer
Highest
1
2
3
4
5
6
7
8
9
10
Lowest

432
423
457
293
278
282
243
325
252
398

.568
.595
.580
.576
.525
.556
.569
.570
.560
.547

1.00
1.05
1.02
1.01
0.92
0.98
1.00
1.00
0.99
0.96

...
(0.94, 1.18)
(0.92, 1.13)
(0.94, 1.09)
(0.79, 1.07)
(0.85, 1.13)
(0.80, 1.26)
(0.91, 1.10)
(0.93, 1.05)
(0.83, 1.11)

80
125
103
90
130
94
117
160
110
103

...
(0.67, 1.51)
(0.69, 1.14)
(0.72, 1.15)
(0.63, 1.02)c
(0.73, 1.16)
(0.65, 1.06)
(0.66, 1.03)c
(0.72, 1.15)
(0.53, 0.90)

Note. ICD-9 = International Classification of Diseases, Ninth Revision; n = number of cumulative incident cancer cases; SR = cumulative survival
rate; SRR = survival rate ratio; CI = confidence interval.
a
A survival rate ratio of 1.00 is the baseline.
b
Confidence intervals are based on the Mantel-Haenszel χ2 test.
c
Approached statistical significance: 90% confidence interval does not intersect the null value of 1.00.

also consistent with this study’s findings.45 It is
possible—but, we think, improbable—that
other factors may account for this study’s findings. In addition to its unique health insurance
system, Hawaii also has a relatively unique ethnic distribution and at least the suggestion of a
significantly different lifestyle than elsewhere.
As elsewhere, race/ethnicity and lifestyle
factors such as diet and smoking have been observed to be associated with the occurrence and
prognosis of some cancers,46–55 although the effects, particularly for survival, may generally be
categorized as very small. The majority of cancer case patients we studied in Honolulu were
Asian Americans or Pacific Islanders (63%);
most of the others were White (32%).37,38 It was
not possible to mathematically adjust for this factor, as the Ontario Cancer Registry does not routinely code race/ethnicity. However, we did replicate the between-country comparisons with the
non-White and White Honolulu cohorts. Although there were some power problems, these
analyses did not result in any practical alteration
of our findings. We think that the ethnicity/
lifestyle hypotheses are not particularly potent
alternative explanations, for a number of other
reasons.
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1. The findings within Hawaii were as divergent from those of other states, as were the
between-country ones.
2. Asian Americans and Pacific Islanders
are by no means a homogeneous group of
people. In fact, evidence suggests that regarding breast cancer survival among Hawaiian residents, for example, Native Hawaiian,
Filipino, and Chinese people may be disadvantaged relative to Whites, while Japanese
people are advantaged.49
3. Toronto may also be generally characterized as a multicultural population, although
not to the same degree as Honolulu. Approximately a third of Toronto’s residents are people
of color, and nearly one quarter of them emigrated during the past 10 years.35
4. The so-called Hawaiian lifestyle
seems to be based more in mythology than
empiricism. The prevalence of actual relevant
risky behaviors (lack of exercise, overweight,
smoking, and excessive alcohol consumption) among Hawaiians has been observed to
be strikingly similar to that of most other
states.56 Therefore, whatever influences ethnicity and lifestyle impart in such survival
analyses, they are not likely to be systematic,

and so they are not likely to confound this
study’s findings.
In fact, we believe that if there is any
bias in this study’s Canada–US comparative
analyses of low-income groups, it is probably that its SRR point estimates are underestimates of the truth, for the following
reasons.
1. Whereas both female life expectancy
and male life expectancy at birth are more
than 2 years greater in Canada than in the
United States, these figures are more than 3
years greater for Honolulu than for
Toronto.57–60
2. Any information bias due to ecologic
measurement of SES is likely to be similarly
nondifferential among this study’s Canadian
and US samples1–3,5,61–70; relatedly, owing to
this study’s focus on 10 socioeconomic areas
(in Honolulu, median household incomes in
these areas in 1990 ranged from $21 420 to
$61384), actual socioeconomic variability, and
therefore the ability to detect meaningful effects, was substantially diminished (Honolulu
median incomes across its 190 census tracts
ranged from $5000 to $149850).
December 2000, Vol. 90, No. 12

3. In focusing on all-cause rather than
cancer-specific censored survival, this study
used a more conservative analytic approach,
in that cancer-specific death rates may underestimate the mortality associated with a diagnosis of cancer.71 Recall also that cancer was
the underlying cause of the vast majority of
deaths, particularly among the younger cohort
not eligible for Medicare. Moreover, the underlying cause of the majority of “noncancer”
deaths—respiratory and circulatory problems—can often be directly associated with
the treatment of cancer or, for that matter, with
its nontreatment. We therefore believe that this
study’s findings are best characterized as conservative estimates of Canadian–US cancer
outcome differences.

Conclusions
This study’s central finding of advantaged
Canadian vs American cancer survival, particularly among relatively low-income groups,
implicates health care systemic factors as its
most cogent explanation. Although Hawaii’s
prevalent health insurance coverage does seem
attendant with better management of cancer
care than that of other states, people with cancer in Toronto still enjoy a significant survival
advantage. Employer-mandated health insurance coverage certainly seems to be a large
step toward providing more equitable health
care. However, this study provides evidence to
suggest that even better care could be expected
among more Americans through movement to
a more universally accessible, single-payer system such as Canada’s.
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